Mohammad Isreb

1.1k total citations
30 papers, 912 citations indexed

About

Mohammad Isreb is a scholar working on Molecular Biology, Pharmaceutical Science and Biomedical Engineering. According to data from OpenAlex, Mohammad Isreb has authored 30 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pharmaceutical Science and 7 papers in Biomedical Engineering. Recurrent topics in Mohammad Isreb's work include Drug Solubulity and Delivery Systems (7 papers), Additive Manufacturing and 3D Printing Technologies (6 papers) and 3D Printing in Biomedical Research (5 papers). Mohammad Isreb is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Additive Manufacturing and 3D Printing Technologies (6 papers) and 3D Printing in Biomedical Research (5 papers). Mohammad Isreb collaborates with scholars based in United Kingdom, Pakistan and Jordan. Mohammad Isreb's co-authors include Mohamed A. Alhnan, Abdullah Isreb, Tim Gough, Robert T. Forbes, Adrian Kelly, Matthew Peak, Bana Shriky, Najet Mahmoudi, Sarah E. Rogers and Olga Shebanova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Colloid and Interface Science and International Journal of Pharmaceutics.

In The Last Decade

Mohammad Isreb

29 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Isreb United Kingdom 12 504 338 195 152 127 30 912
Ka‐Wai Wan United Kingdom 16 674 1.3× 471 1.4× 174 0.9× 185 1.2× 209 1.6× 19 1.1k
Joanna Szafraniec-Szczęsny Poland 19 745 1.5× 538 1.6× 387 2.0× 191 1.3× 91 0.7× 38 1.4k
Himanshu Kathuria Singapore 19 467 0.9× 237 0.7× 550 2.8× 183 1.2× 223 1.8× 38 1.3k
Janitha M. Unagolla United States 10 578 1.1× 222 0.7× 151 0.8× 318 2.1× 104 0.8× 13 1.0k
Anh Q. Vo United States 14 437 0.9× 316 0.9× 540 2.8× 113 0.7× 172 1.4× 20 1.0k
Ruzica Kolakovic Finland 17 428 0.8× 209 0.6× 212 1.1× 510 3.4× 82 0.6× 21 1.2k
Dinesh Nyavanandi United States 19 368 0.7× 200 0.6× 522 2.7× 266 1.8× 304 2.4× 31 1.3k
Zengming Wang China 14 253 0.5× 131 0.4× 272 1.4× 130 0.9× 112 0.9× 42 693
Witold Jamróz Poland 13 730 1.4× 571 1.7× 234 1.2× 99 0.7× 40 0.3× 20 1.1k
Anastasia Foppoli Italy 25 1.0k 2.0× 775 2.3× 789 4.0× 292 1.9× 150 1.2× 66 2.1k

Countries citing papers authored by Mohammad Isreb

Since Specialization
Citations

This map shows the geographic impact of Mohammad Isreb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Isreb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Isreb more than expected).

Fields of papers citing papers by Mohammad Isreb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Isreb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Isreb. The network helps show where Mohammad Isreb may publish in the future.

Co-authorship network of co-authors of Mohammad Isreb

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Isreb. A scholar is included among the top collaborators of Mohammad Isreb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Isreb. Mohammad Isreb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Najafzadeh, Mohammad Javad, Mojgan Najafzadeh, Mohammad Isreb, et al.. (2024). P161 The use of Novel Natural Treatments for Inflammatory Bowel Diseases. Journal of Crohn s and Colitis. 18(Supplement_1). i461–i461.
3.
4.
Sefat, Farshid, Saeed Heidari Keshel, Karthic Swaminathan, et al.. (2022). Anticarcinogenic impact of extracellular vesicles (exosomes) from cord blood stem cells in malignant melanoma: A potential biological treatment. Journal of Cellular and Molecular Medicine. 27(2). 222–231. 9 indexed citations
5.
Pereira, Beatriz C., Rober Habashy, Matthew Peak, et al.. (2021). Solvent-free temperature-facilitated direct extrusion 3D printing for pharmaceuticals. International Journal of Pharmaceutics. 598. 120305–120305. 38 indexed citations
6.
Isreb, Mohammad, et al.. (2021). Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer. ERJ Open Research. 7(3). 555–2020. 5 indexed citations
7.
Shah, Syed Muhammad Hassan, Syed Wadood Ali Shah, Shahzeb Khan, et al.. (2020). Efficient design to fabricate smart Lumefantrine nanocrystals using DENA® particle engineering technology: Characterisation, in vitro and in vivo antimalarial evaluation and assessment of acute and sub-acute toxicity. Journal of Drug Delivery Science and Technology. 61. 102228–102228. 8 indexed citations
8.
9.
Najafzadeh, Mojgan, et al.. (2020). Anticancer potential of myricetin bulk and nano forms in vitro in lymphocytes from myeloma patients. Archives of Toxicology. 95(1). 337–343. 11 indexed citations
10.
Najafzadeh, Mojgan, et al.. (2020). ROS-induced oxidative damage in lymphocytes ex vivo/in vitro from healthy individuals and MGUS patients: protection by myricetin bulk and nanoforms. Archives of Toxicology. 94(4). 1229–1239. 11 indexed citations
11.
Najafzadeh, Mojgan, et al.. (2020). Ex vivo/in vitro effects of aspirin and ibuprofen, bulk and nano forms, in peripheral lymphocytes of prostate cancer patients and healthy individuals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 861-862. 503306–503306. 7 indexed citations
12.
Bashir, Safdar, Muhammad Asif Khan, Shujaat Ahmad, et al.. (2020). Smart nanocrystal of indomethacin: Nanonization and characterization through top down method of media milling.. Pakistan Journal of Pharmaceutical Sciences. 33(2(Supplementary)). 765–770. 3 indexed citations
13.
14.
Isreb, Abdullah, et al.. (2019). 3D printed oral theophylline doses with innovative ‘radiator-like’ design: Impact of polyethylene oxide (PEO) molecular weight. International Journal of Pharmaceutics. 564. 98–105. 126 indexed citations
15.
Shriky, Bana, Adrian Kelly, Mohammad Isreb, et al.. (2019). Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development. Journal of Colloid and Interface Science. 565. 119–130. 217 indexed citations
16.
Bashir, Sajid, et al.. (2018). Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector. Drug Design Development and Therapy. Volume 12. 2617–2626. 12 indexed citations
17.
Arafat, Basel, Abdullah Isreb, Robert T. Forbes, et al.. (2018). Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. European Journal of Pharmaceutical Sciences. 118. 191–199. 148 indexed citations
18.
Sadia, Muzna, et al.. (2018). From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. European Journal of Pharmaceutical Sciences. 123. 484–494. 95 indexed citations
19.
Najafzadeh, Mojgan, et al.. (2016). DNA Damage in Healthy Individuals and Respiratory Patients after Treating Whole Blood In vitro with the Bulk and Nano Forms of NSAIDs. Frontiers in Molecular Biosciences. 3. 50–50. 13 indexed citations
20.
Shah, Syed Muhammad Hassan, Farhat Ullah, Shahzeb Khan, et al.. (2016). Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation. Drug Design Development and Therapy. Volume 10. 3837–3850. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ka‐Wai Wan Breakdown of academic impact, for papers by Joanna Szafraniec-Szczęsny Breakdown of academic impact, for papers by Himanshu Kathuria Breakdown of academic impact, for papers by Janitha M. Unagolla Breakdown of academic impact, for papers by Anh Q. Vo Breakdown of academic impact, for papers by Ruzica Kolakovic Breakdown of academic impact, for papers by Dinesh Nyavanandi Breakdown of academic impact, for papers by Zengming Wang Breakdown of academic impact, for papers by Witold Jamróz Breakdown of academic impact, for papers by Anastasia Foppoli
Rankless by CCL
2026